715 related articles for article (PubMed ID: 30527792)
41. Aphasia predicts unfavorable outcome in mild ischemic stroke patients and prompts thrombolytic treatment.
Nesi M; Lucente G; Nencini P; Fancellu L; Inzitari D
J Stroke Cerebrovasc Dis; 2014 Feb; 23(2):204-8. PubMed ID: 23352114
[TBL] [Abstract][Full Text] [Related]
42. Symptomatic intracerebral hemorrhage after intravenous thrombolysis in Chinese patients: comparison of prediction models.
Li M; Wang-Qin RQ; Wang YL; Liu LB; Pan YS; Liao XL; Wang YJ; Xu AD
J Stroke Cerebrovasc Dis; 2015 Jun; 24(6):1235-43. PubMed ID: 25891755
[TBL] [Abstract][Full Text] [Related]
43. Very Early versus Delayed Rehabilitation for Acute Ischemic Stroke Patients with Intravenous Recombinant Tissue Plasminogen Activator: A Nationwide Retrospective Cohort Study.
Momosaki R; Yasunaga H; Kakuda W; Matsui H; Fushimi K; Abo M
Cerebrovasc Dis; 2016; 42(1-2):41-8. PubMed ID: 26986718
[TBL] [Abstract][Full Text] [Related]
44. Intravenous Tissue Plasminogen Activator for Wake-Up Stroke: A Propensity Score-Matched Analysis.
Anaissie JE; Monlezun DJ; Siegler JE; Waring ED; Dowell LN; Samai AA; George AJ; Kimbrough T; Berthaud J; Martin-Schild S
J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2603-2609. PubMed ID: 27476340
[TBL] [Abstract][Full Text] [Related]
45. Validation of FLAIR hyperintense lesions as imaging biomarkers to predict the outcome of acute stroke after intra-arterial thrombolysis following intravenous tissue plasminogen activator.
Chung JW; Kim KJ; Noh WY; Jang MS; Yang MH; Han MK; Kwon OK; Jung C; Kim JH; Oh CW; Lee JS; Lee J; Bae HJ
Cerebrovasc Dis; 2013; 35(5):461-8. PubMed ID: 23735898
[TBL] [Abstract][Full Text] [Related]
46. Changes in Activated Thrombin-Activatable Fibrinolysis Inhibitor Levels Following Thrombolytic Therapy in Ischemic Stroke Patients Correlate with Clinical Outcome.
Alessi MC; Gaudin C; Grosjean P; Martin V; Timsit S; Mahagne MH; Larrue V; Sibon I; Zuber M; Brouns R; Montaner J; Castellanos M; Donazzolo Y; Cho TH; Suissa L; Mechtouff L; Derex L; Suchon P; Mezzapesa A; Nighoghossian N
Cerebrovasc Dis; 2016; 42(5-6):404-414. PubMed ID: 27387478
[TBL] [Abstract][Full Text] [Related]
47. Temporal Trends in Intravenous Thrombolysis in Acute Ischemic Stroke: Experience from a Tertiary Care Center in India.
Khurana D; Das B; Kumar A; Kumar S A; Khandelwal N; Lal V; Prabhakar S
J Stroke Cerebrovasc Dis; 2017 Jun; 26(6):1266-1273. PubMed ID: 28237123
[TBL] [Abstract][Full Text] [Related]
48. Efficacy of Tirofiban Administered at Different Time Points after Intravenous Thrombolytic Therapy with Alteplase in Patients with Acute Ischemic Stroke.
Liu J; Shi Q; Sun Y; He J; Yang B; Zhang C; Guo R
J Stroke Cerebrovasc Dis; 2019 Apr; 28(4):1126-1132. PubMed ID: 30655038
[TBL] [Abstract][Full Text] [Related]
49. Thrombolytic Therapy in Severe Cardioembolic Stroke After Reversal of Dabigatran with Idarucizumab: Case Report and Literature Review.
Ohya Y; Makihara N; Wakisaka K; Morita T; Ago T; Kitazono T; Takaba H
J Stroke Cerebrovasc Dis; 2018 Jul; 27(7):e128-e131. PubMed ID: 29555397
[TBL] [Abstract][Full Text] [Related]
50. Endovascular Treatment With or Without Prior Intravenous Alteplase for Acute Ischemic Stroke.
Chalos V; LeCouffe NE; Uyttenboogaart M; Lingsma HF; Mulder MJHL; Venema E; Treurniet KM; Eshghi O; van der Worp HB; van der Lugt A; Roos YBWEM; Majoie CBLM; Dippel DWJ; Roozenbeek B; Coutinho JM;
J Am Heart Assoc; 2019 Jun; 8(11):e011592. PubMed ID: 31140355
[TBL] [Abstract][Full Text] [Related]
51. Fibrinogen concentrate replacement in ischemic stroke patients after recombinant tissue plasminogen activator treatment.
Vandelli L; Marietta M; Trenti T; Varani M; Bigliardi G; Rosafio F; Dell'acqua ML; Picchetto L; Nichelli P; Zini A
Adv Clin Exp Med; 2019 Feb; 28(2):219-222. PubMed ID: 30507073
[TBL] [Abstract][Full Text] [Related]
52. Safety of Intravenous Thrombolysis in Chronic Intracranial Hemorrhage: A Five-Year Multicenter Study.
Zand R; Tsivgoulis G; Sadighi A; Singh M; McCormack M; Shahjouei S; Goyal N; Noorbakhsh-Sabet N; Alexandrov AW; Alexandrov AV
J Stroke Cerebrovasc Dis; 2018 Mar; 27(3):620-624. PubMed ID: 29100859
[TBL] [Abstract][Full Text] [Related]
53. Correlation of Changes in Leukocytes Levels 24 Hours after Intravenous Thrombolysis With Prognosis in Patients With Acute Ischemic Stroke.
Chen J; Zhang Z; Chen L; Feng X; Hu W; Ge W; Li X; Jin P; Shao B
J Stroke Cerebrovasc Dis; 2018 Oct; 27(10):2857-2862. PubMed ID: 30064868
[TBL] [Abstract][Full Text] [Related]
54. Idarucizumab for Intravenous Thrombolysis and Endovascular Thrombectomy in Acute Stroke: A Case Report.
Lin YT; Lai YJ; Lai TH
J Emerg Med; 2020 Mar; 58(3):e113-e116. PubMed ID: 31744711
[TBL] [Abstract][Full Text] [Related]
55. Treatment With Intravenous Alteplase for Acute Ischemic Stroke After Reversal of Dabigatran With Idarucizumab: A Case Study.
Jala S; O'Brien E
J Neurosci Nurs; 2019 Feb; 51(1):21-25. PubMed ID: 30489421
[TBL] [Abstract][Full Text] [Related]
56. A Fall in Systolic Blood Pressure 24 Hours after Thrombolysis for Acute Ischemic Stroke Is Associated with Early Neurological Recovery.
Gill D; Cox T; Aravind A; Wilding P; Korompoki E; Veltkamp R; Kar A
J Stroke Cerebrovasc Dis; 2016 Jun; 25(6):1539-43. PubMed ID: 27053029
[TBL] [Abstract][Full Text] [Related]
57. Revascularization outcomes following acute ischemic stroke in patients taking direct oral anticoagulants: a single hospital cohort study.
Frol S; Šabovič M; Popovič KŠ; Oblak JP
J Thromb Thrombolysis; 2021 Jan; 51(1):194-202. PubMed ID: 32506363
[TBL] [Abstract][Full Text] [Related]
58. Intravenous Thrombolysis for Acute Ischemic Stroke due to Cervical Internal Carotid Artery Occlusion.
Yeo LL; Kong WY; Paliwal P; Teoh HL; Seet RC; Soon D; Rathakrishnan R; Ong V; Lee TH; Wong HF; Chan BP; Leow WK; Yuan C; Ting E; Gopinathan A; Tan BY; Sharma VK
J Stroke Cerebrovasc Dis; 2016 Oct; 25(10):2423-9. PubMed ID: 27344361
[TBL] [Abstract][Full Text] [Related]
59. Outcome of stroke patients receiving different doses of recombinant tissue plasminogen activator.
Ong CT; Wong YS; Wu CS; Su YH
Drug Des Devel Ther; 2017; 11():1559-1566. PubMed ID: 28572721
[TBL] [Abstract][Full Text] [Related]
60. High Plasma D-Dimer Indicates Unfavorable Outcome of Acute Ischemic Stroke Patients Receiving Intravenous Thrombolysis.
Hsu PJ; Chen CH; Yeh SJ; Tsai LK; Tang SC; Jeng JS
Cerebrovasc Dis; 2016; 42(1-2):117-21. PubMed ID: 27088493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
